Marché nord-américain de l’IRM cérébrale – Tendances et prévisions du secteur jusqu’en 2029

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché nord-américain de l’IRM cérébrale – Tendances et prévisions du secteur jusqu’en 2029

  • Medical Devices
  • Publish Reports
  • Mar 2022
  • North America
  • 350 Pages
  • Nombre de tableaux : 90
  • Nombre de figures : 42

>Marché nord-américain de l'IRM cérébrale, par type de scanner (faible intensité de champ (IRM machine IRM debout ou assise ), type de trouble cérébral (tumeur cérébrale, démence, maladie d'Alzheimer, maladie de Parkinson, épilepsie et crise, accident vasculaire cérébral, sclérose en plaques et autres), utilisateur final (hôpitaux, centres d'imagerie et de diagnostic, centres de chirurgie ambulatoire et autres), canal de distribution (appel d'offres direct, ventes au détail), tendances de l'industrie et prévisions jusqu'en 2029

Marché nord-américain de l'IRM cérébrale

Analyse et perspectives du marché : marché nord-américain de l'IRM cérébrale

L'IRM cérébrale est un trouble neurologique rare dans lequel le cerveau d'un enfant se développe de manière anormale pendant la grossesse. Il se développe en raison d'un échec de la migration neuronale qui se produit entre 12 et 24 semaines de gestation, ce qui entraîne l'absence de développement normal des circonvolutions et des sillons cérébraux. Une sonde de gastrostomie est insérée dans l'estomac des enfants souffrant de difficultés d'alimentation et de déglutition. Selon les recherches, elle peut être causée par un dysfonctionnement de plusieurs gènes. La majorité de ces altérations génétiques ne sont pas toujours héritées des parents. Lorsqu'il n'y a pas d'antécédents familiaux de la maladie, elles peuvent apparaître de manière aléatoire dans la constitution génétique d'une personne.

L'IRM cérébrale en Amérique du Nord est encourageante et vise à réduire la gravité des symptômes. Data Bridge Market Research analyse que le marché de l'IRM cérébrale connaîtra un TCAC de 5,1 % au cours de la période de prévision de 2022 à 2029.

Rapport métrique

Détails

Période de prévision

2022 à 2029

Année de base

2021

Années historiques

2020 (personnalisable de 2019 à 2014)

Unités quantitatives

Chiffre d'affaires en millions USD, prix en USD

Segments couverts

Par type de scanner (faible intensité de champ (IRM < 1,5 t), intensité de champ moyenne (IRM 1,5 t à IRM 3,0 t et intensité de champ élevée (4 t et plus)), type de machine (machine IRM ouverte, machine IRM fermée et machine IRM debout ou assise), type de trouble cérébral (tumeur cérébrale, démence, maladie d'Alzheimer, maladie de Parkinson, épilepsie et crise, accident vasculaire cérébral, sclérose en plaques et autres), utilisateur final (hôpitaux, centres d'imagerie et de diagnostic, centres de chirurgie ambulatoire et autres), canal de distribution (appel d'offres direct, vente au détail)

Pays couverts

États-Unis, Canada et Mexique

Acteurs du marché couverts

Société royale Philips NV General Electric Company, FUJIFILM Holdings America Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, ESAOTE SPA, Hyperfine, Time Medical Holding, Shenzhen Anke High-tech Co, Ltd, UNITED IMAGING, SternMed GmbH, Beijing Wandong Medical Technology Co., Ltd, BASDA, Ultravision Medical Equipment Trading LLC, Neusoft Corporation, Elekta AB, alltech Medical Systems America, FONAR Corp, Bruker, Aspect Imaging Ltd, ASG Superconductors spa, MinFound Medical Systems Co., Ltd et Synaptive Medical

Dynamique  du marché de l'IRM cérébrale

Conducteurs

  • Rise in prevalence and incidence of chronic neurological diseases

The rise in the incidences of the neurological diseases such as stroke and dementia will increase the diagnosis and use of brain MRI scan devices and hence act as a major driver that will result in the expansion of the growth rate of the market.

For instance,

  • In 2021, the data by the Family Caregiver Alliance, stated, that more than 600,000 people in the U.S. were diagnosed with stroke and 250,000 people with Alzheimer’s disease. 1.2 million people aged 18 years and older were diagnosed annually with adult onset brain disorders in the U.S.
  • The rise in product approvals

Another significant factor influencing the growth rate of the brain MRI scan market are the approvals for the use of brain MRI scan, which helps in improving its infrastructure.

  • The growth in technological developments in the mid field strength MRI devices

Also, the increase in the growth in technological developments in the mid field strength MRI devices such as artificial intelligence and ultrasound will further enhance the growth of the brain MRI scan market.

Furthermore, advancement in medical technology, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the rain MRI scan market. Other factors such as increase in the demand for effective therapies and rising awareness about the timely diagnosis and will positively impact the brain MRI scan market's growth rate. Additionally, high disposable income, rising number of cases of seizures and changing lifestyle will result in the expansion of the brain MRI scan market. 

Opportunities

  • The rise in healthcare expenditure

Moreover, the rise in the research and development activities and increasing investments by government and private organization will boost new opportunities for the market's growth rate.

Also, the launch of effective therapies and continuous clinical trials will provide beneficial opportunities for the Brain MRI scan market in the forecast period of 2022-2029. Also, high unmet need of current and developments in healthcare technology will escalate the growth rate of the brain MRI scan market in future.

Restraints/Challenges

However, high cost associated with the available and lack of infrastructure in low-income countries will impede the growth rate of brain MRI scan market. Additionally, the risks incurred while using the MRI devices will hinder the brain MRI scan market growth. The lack of cure for this neurological condition and less awareness about genetic and rare diseases will further challenge the market in the forecast period mentioned above.

The brain MRI scan market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on brain MRI scan market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

 Brain MRI scan is a brain disorder that is relatively uncommon and whose incidence is unknown. According to a study by the family caregiver alliance, state that around 250,000 people are diagnosed with Alzheimer’s disease.

Brain MRI scan market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Covid-19 Impact on the Brain MRI Scan Market

The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the diagnosis management and treatment. The lack of access to health-care facilities for routine and medication administration will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in anticonvulsant medication adherence during the pandemic.

Recent Development

  • In December 2020, during the pandemic, BASDA had launched liquid helium-free 1.5t superconducting MRI scanner, in China. The product launch had improved the product range of superconducting MRI segment. It would make the 1.5t superconducting MRI scanner, available in imaging and diagnostic centers in China. It is expected to increase the revenue

Marché nord-américain de l'IRM cérébrale

North America Brain MRI Scan Market Scope

The Brain MRI scan market is segmented on the basis of scanner type, machine type, brain disorder, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Scanner Type

  • Low Field Strength (<1.5T MRI)
  • Mid Field Strength (1.5T MRI to 3.0T MRI)
  • High Field Strength (4T and Above)

On the basis of scanner type, the mid field strength is sub-segmented into low field strength (<1.5T MRI), mid field strength (1.5T MRI to 3.0T MRI) and high field strength (4T and above).

Machine Type

  • Open MRI Machine
  • Closed MRI Machine
  • Standing or Sitting MRI Machine

On the basis of machine type, the North America brain MRI scan market is segmented into open MRI   machine, closed MRI   machine and standing or sitting MRI machine.

Brain Disorder

  • Brain Tumor
  • Dementia
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Epilepsy and Seizure
  • Stroke
  • Multiple Sclerosis
  • Others.

On the basis of brain disorder, the North America brain MRI scan market is segmented into brain tumor, dementia, Alzheimer’s disease, Parkinson’s disease, epilepsy and seizure, stroke, multiple sclerosis, and others.

End User

  • Hospitals
  • Imaging and Diagnostic Centers
  • Ambulatory Surgery Centers
  • Others

On the basis of end user, the North America brain MRI scan market is segmented into hospitals, imaging and diagnostic centers, ambulatory surgery centers, and others.

Distribution Channel

  • Direct Tenders
  • Retail Sales

On the basis of distribution channel, the North America brain MRI scan market is segmented into direct tenders, retail sales.

Pipeline Analysis (not provided)

Brain MRI Scan Market Country Analysis/Insights

North America brain MRI scan market is analysed and market size insights and trends are provided by country, scanner type, machine type, brain disorder, end-users and distribution channel.  as referenced above.

The countries covered in the brain MRI scan market report are U.S., Canada and Mexico in North America.

The U.S. dominates the brain MRI scan market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this region and availability of advanced MRI scan devices.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Brain MRI Scan Market Share Analysis

Le paysage concurrentiel du marché de l'IRM cérébrale en Amérique du Nord fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence en Amérique du Nord, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché de l'IRM cérébrale.

Français Certains des principaux acteurs opérant sur le marché de l'IRM cérébrale sont Koninklijke Philips NV General Electric Company, FUJIFILM Holdings America Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, ESAOTE SPA, Hyperfine, Time Medical Holding., Shenzhen Anke High-tech Co, Ltd., UNITED IMAGING, SternMed GmbH., Beijing Wandong Medical Technology Co., Ltd., BASDA, Ultravision Medical Equipment Trading LLC, Neusoft Corporation, Elekta AB, alltech Medical Systems America, FONAR Corp, Bruker, Aspect Imaging Ltd., ASG Superconductors spa, MinFound Medical Systems Co., Ltd et Synaptive Medical, entre autres.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA BRAIN MRI SCAN MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 NORTH AMERICA BRAIN MRI SCAN MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTERS FIVE FORCES

4.3 NUMER OF PATIENTS GETTING PERIODIC HEALTH EXAMINATIONS (PHE) USING MRI

5 NORTH AMERICA BRAIN MRI SCAN MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISE IN PREVALENCE AND INCIDENCE OF NEUROLOGICAL DISORDERS

6.1.2 AWARENESS AMONG POPULATION ABOUT THE TREATMENT AND USE OF BRAIN SCAN MRIDEVICES

6.1.3 TECHNOLOGICAL ADVANCEMENTS IN BRAIN MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES

6.1.4 FAVORABLE REIMBURSEMENT POLICIES

6.1.5 RISE IN PRODUCT APPROVALS

6.2 RESTRAINTS

6.2.1 RISE IN COST OF THE MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES

6.2.2 RISKS NOTICED WHILE USING MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES

6.2.3 RISE IN PRODUCT RECALL

6.2.4 AVAILABILITY OF ALTERNATE IMAGING DIAGNOSTIC DEVICES

6.3 OPPORTUNITIES

6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS

6.3.2 RISE IN HEALTHCARE EXPENDITURE

6.3.3 INCREASE IN DEMAND FOR NON-INVASIVE MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES

6.4 CHALLENGES

6.4.1 LACK OF SKILLED PROFESSIONALS REQUIRED FOR USE OF BRAIN MRI SCAN DEVICES

6.4.2 STRINGENT REGULATIONS

7 NORTH AMERICA BRAIN MRI SCAN MARKET, BY SCANNER TYPE

7.1 OVERVIEW

7.2 MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI)

7.2.1 FIELD STRENGTH 1.5T

7.2.2 FIELD STRENGTH 3T

7.3 LOW FIELD STRENGTH (<1.5T MRI)

7.4 HIGH FIELD STRENGTH (4T AND ABOVE)

8 NORTH AMERICA BRAIN MRI SCAN MARKET, BY MACHINE TYPE

8.1 OVERVIEW

8.2 CLOSED MRI MACHINE

8.3 OPEN MRI MACHINE

8.4 STANDING OR SITTING MRI MACHINE

9 NORTH AMERICA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER

9.1 OVERVIEW

9.2 DEMENTIA

9.2.1 BY MACHINE TYPE

9.2.1.1 CLOSED MRI MACHINE

9.2.1.2 OPEN MRI MACHINE

9.2.1.3 STANDING OR SITTING MRI MACHINE

9.3 ALZHEIMER'S DISEASE

9.3.1 BY MACHINE TYPE

9.3.1.1 CLOSED MRI MACHINE

9.3.1.2 OPEN MRI MACHINE

9.3.1.3 STANDING OR SITTING MRI MACHINE

9.4 EPILEPSY AND SEIZURE

9.4.1 BY MACHINE TYPE

9.4.1.1 CLOSED MRI MACHINE

9.4.1.2 OPEN MRI MACHINE

9.4.1.3 STANDING OR SITTING MRI MACHINE

9.5 PARKINSON'S DISEASE

9.5.1 BY MACHINE TYPE

9.5.1.1 CLOSED MRI MACHINE

9.5.1.2 OPEN MRI MACHINE

9.5.1.3 STANDING OR SITTING MRI MACHINE

9.6 STROKE

9.6.1 BY MACHINE TYPE

9.6.1.1 CLOSED MRI MACHINE

9.6.1.2 OPEN MRI MACHINE

9.6.1.3 STANDING OR SITTING MRI MACHINE

9.7 MULTIPLE SCLEROSIS

9.7.1 BY MACHINE TYPE

9.7.1.1 CLOSED MRI MACHINE

9.7.1.2 OPEN MRI MACHINE

9.7.1.3 STANDING OR SITTING MRI MACHINE

9.8 BRAIN TUMOR

9.8.1 BY MACHINE TYPE

9.8.1.1 CLOSED MRI MACHINE

9.8.1.2 OPEN MRI MACHINE

9.8.1.3 STANDING OR SITTING MRI MACHINE

9.9 OTHER BRAIN DISORDERS

10 NORTH AMERICA BRAIN MRI SCAN MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 IMAGING DIAGNOSTIC CENTERS

10.4 AMBULATORY SURGERY CENTERS

10.5 OTHERS

11 NORTH AMERICA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDER

11.3 RETAIL SALES

12 NORTH AMERICA BRAIN MRI SCAN MARKET, BY REGION

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA BRAIN MRI SCAN MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 SIEMENS AG

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.1.5.1 ACQUISITION

15.2 GENERAL ELECTRIC COMPANY

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.2.5.1 PRODUCT APPROVAL

15.3 CANON MEDICAL SYSTEMS CORPORATION (A SUBSIDIARY OF CANON INC.)

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENTS

15.4 KONINKLIJKE PHILIPS N.V

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 FUJIFILM HOLDINGS AMERICA CORPORATION (2021)

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENT

15.6 ELEKTA AB

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUS ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 ALLTECH MEDICAL SYSTEMS

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENTS

15.8 ASPECT IMAGING

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 ASG SUPERCONDUCTORS SPA

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 BRUKER (2021)

15.10.1 COMPANY SNAPSHOT

15.10.2 REVENUE ANALYSIS

15.10.3 PRODUCT PORTFOLIO

15.10.4 RECENT DEVELOPMENT

15.11 BASDA

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENT

15.12 BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD (2021)

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENTS

15.13 ESAOTE SPA

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.13.3.1 PRODUCT APPROVAL

15.14 FONAR CORP.

15.14.1 COMPANY SNAPSHOT

15.14.2 REVENUS ANALYSIS

15.14.3 PRODUCT PORTFOLIO

15.14.4 RECENT DEVELOPMENT

15.15 HYPERFINE

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 MINFOUND MEDICAL SYSTEMS CO.

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 MEDONICA CO. LTD

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENTS

15.18 NEUSOFT MEDICAL SYSTEMS

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENT

15.19 STEMLAB, INC.

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENT

15.2 STERNMED GMBH

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENTS

15.21 SYNAPTIVE MEDICAL

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

15.22 SHENZHEN ANKE HIGH-TECH CO., LTD.

15.22.1 COMPANY SNAPSHOT

15.22.2 PRODUCT PORTFOLIO

15.22.3 RECENT DEVELOPMENT

15.23 TIME MEDICAL HOLDING

15.23.1 COMPANY SNAPSHOT

15.23.2 PRODUCT PORTFOLIO

15.23.3 RECENT DEVELOPMENTS

15.24 VOXELGRIDS

15.24.1 COMPANY SNAPSHOT

15.24.2 PRODUCT PORTFOLIO

15.24.3 RECENT DEVELOPMENTS

15.25 UNITED IMAGING

15.25.1 COMPANY SNAPSHOT

15.25.2 PRODUCT PORTFOLIO

15.25.3 RECENT DEVELOPMENT

15.26 ULTRAVISION MEDICAL EQUIPMENT TRADING L.L.C

15.26.1 COMPANY SNAPSHOT

15.26.2 PRODUCT PORTFOLIO

15.26.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

Liste des tableaux

TABLE 2 NORTH AMERICA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 NORTH AMERICA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)

TABLE 4 NORTH AMERICA LOW FIELD STRENGTH (<1.5T MRI) IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 NORTH AMERICA HIGH FIELD STRENGTH (4T AND ABOVE) IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 NORTH AMERICA CLOSED MRI MACHINE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 NORTH AMERICA OPEN MRI MACHINE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 NORTH AMERICA STANDING OR SITTING MRI MACHINE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 NORTH AMERICA DEMENTIA IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 NORTH AMERICA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 13 NORTH AMERICA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 NORTH AMERICA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 15 NORTH AMERICA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 NORTH AMERICA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 17 NORTH AMERICA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 NORTH AMERICA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 19 NORTH AMERICA STROKE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 NORTH AMERICA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 21 NORTH AMERICA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 NORTH AMERICA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 23 NORTH AMERICA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 NORTH AMERICA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 25 NORTH AMERICA OTHER BRAIN DISORDERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 NORTH AMERICA HOSPITALS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 NORTH AMERICA IMAGING DIAGNOSTIC CENTERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 NORTH AMERICA AMBULATORY SURGERY CENTERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 NORTH AMERICA OTHERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 NORTH AMERICA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 32 NORTH AMERICA DIRECT TENDER IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 NORTH AMERICA RETAIL SALES IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 NORTH AMERICA BRAIN MRI SCAN MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 38 NORTH AMERICA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)

TABLE 39 NORTH AMERICA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 41 NORTH AMERICA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 43 NORTH AMERICA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)

TABLE 48 NORTH AMERICA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 49 U.S.BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)

TABLE 50 U.S.MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI)IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)

TABLE 51 U.S.BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 52 U.S.BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)

TABLE 53 U.S.DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 54 U.S.ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 55 U.S.EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 56 U.S.PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 57 U.S.STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 58 U.S.MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 59 U.S.BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 60 U.S.BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 61 U.S.BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)

TABLE 62 U.S.BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 63 CANADA BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)

TABLE 64 CANADA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI)IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)

TABLE 65 CANADA BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 66 CANADA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)

TABLE 67 CANADA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 68 CANADA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 69 CANADA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 70 CANADA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 71 CANADA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 72 CANADA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 73 CANADA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 74 CANADA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 75 CANADA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (VOLUME)

TABLE 76 CANADA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 77 MEXICO BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)

TABLE 78 MEXICO MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI)IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)

TABLE 79 MEXICO BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 80 MEXICO BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)

TABLE 81 MEXICO DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 82 MEXICO ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 83 MEXICO EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 84 MEXICO PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 85 MEXICO STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 86 MEXICO MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 87 MEXICO BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)

TABLE 88 MEXICO BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 89 MEXICO BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (VOLUME)

TABLE 90 MEXICO BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

Liste des figures

FIGURE 1 NORTH AMERICA BRAIN MRI SCAN MARKET : SEGMENTATION

FIGURE 2 NORTH AMERICA BRAIN MRI SCAN MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA BRAIN MRI SCAN MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA BRAIN MRI SCAN MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA BRAIN MRI SCAN MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA BRAIN MRI SCAN MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA BRAIN MRI SCAN MARKET: DBMR POSITION GRID

FIGURE 8 NORTH AMERICA BRAIN MRI SCAN MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 NORTH AMERICA BRAIN MRI SCAN MARKET: END USER COVERAGE GRID

FIGURE 10 NORTH AMERICA BRAIN MRI SCAN MARKET: SEGMENTATION

FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA BRAIN MRI SCAN MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 INCREASED PREVALENCE OF NEUOROLOGICAL DISEASES RRISE IN TECHNOLOGICAL ADVANCEMENTS IN NON-INVASIVE BRAIN SCAN MRI DEVICES AND PRODUCT APPPROVALS IS EXPECTED TO DRIVE NORTH AMERICA BRAIN MRI SCAN MARKET FROM 2022 TO 2029

FIGURE 13 SCANNER TYPE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE NORTH AMERICA BRAIN MRI SCAN MARKET FROM 2022 & 2029

FIGURE 14 TOTAL PATIENTS UNDERGOING PERIODIC HEALTH EXAMINATION USING MRI (IN MILLION0

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA BRAIN MRI SCAN MARKET

FIGURE 16 INCIDENCE OF ADULT ONSET BRAIN DISORDERS IN THE U.S. IN 2021

FIGURE 17 NORTH AMERICA BRAIN MRI SCAN MARKET: BY SCANNER TYPE, 2021

FIGURE 18 NORTH AMERICA BRAIN MRI SCAN MARKET: BY SCANNER TYPE, 2020-2029 (USD MILLION)

FIGURE 19 NORTH AMERICA BRAIN MRI SCAN MARKET: BY SCANNER TYPE, CAGR (2022-2029)

FIGURE 20 NORTH AMERICA BRAIN MRI SCAN MARKET: BY SCANNER TYPE, LIFELINE CURVE

FIGURE 21 NORTH AMERICA BRAIN MRI SCAN MARKET: BY MACHINE TYPE, 2021

FIGURE 22 NORTH AMERICA BRAIN MRI SCAN MARKET: BY MACHINE TYPE, 2020-2029 (USD MILLION)

FIGURE 23 NORTH AMERICA BRAIN MRI SCAN MARKET: BY MACHINE TYPE, CAGR (2022-2029)

FIGURE 24 NORTH AMERICA BRAIN MRI SCAN MARKET: BY MACHINE TYPE, LIFELINE CURVE

FIGURE 25 NORTH AMERICA BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, 2021

FIGURE 26 NORTH AMERICA BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, 2020-2029 (USD MILLION)

FIGURE 27 NORTH AMERICA BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, CAGR (2022-2029)

FIGURE 28 NORTH AMERICA BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, LIFELINE CURVE

FIGURE 29 NORTH AMERICA BRAIN MRI SCAN MARKET: BY END USER, 2021

FIGURE 30 NORTH AMERICA BRAIN MRI SCAN MARKET: BY END USER, 2020-2029 (USD MILLION)

FIGURE 31 NORTH AMERICA BRAIN MRI SCAN MARKET: BY END USER, CAGR (2022-2029)

FIGURE 32 NORTH AMERICA BRAIN MRI SCAN MARKET: BY END USER, LIFELINE CURVE

FIGURE 33 NORTH AMERICA BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 34 NORTH AMERICA BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

FIGURE 35 NORTH AMERICA BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 36 NORTH AMERICA BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 37 NORTH AMERICA BRAIN MRI SCAN MARKET: SNAPSHOT (2021)

FIGURE 38 NORTH AMERICA BRAIN MRI SCAN MARKET: BY COUNTRY (2021)

FIGURE 39 NORTH AMERICA BRAIN MRI SCAN MARKET: BY REGION (2022 & 2029)

FIGURE 40 NORTH AMERICA BRAIN MRI SCAN MARKET: BY REGION (2021 & 2029)

FIGURE 41 NORTH AMERICA BRAIN MRI SCAN MARKET: BY SCANNER TYPE (2022-2029)

FIGURE 42 NORTH AMERICA BRAIN MRI SCAN MARKET: COMPANY SHARE 2021 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The North America Brain MRI Scan Market will grow at a CAGR of 5.1% during the forecast period of 2022 to 2029.
The rise in the incidences of the neurological diseases such as stroke and dementia will increase the diagnosis and use of brain MRI scan devices are the significant factors flourishing the growth of the North America Brain MRI Scan Market.
Koninklijke Philips N.V. General Electric Company, FUJIFILM Holdings America Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, ESAOTE SPA, Hyperfine, Time Medical Holding., Shenzhen Anke High-tech Co, Ltd., UNITED IMAGING, SternMed GmbH., Beijing Wandong Medical Technology Co., Ltd., BASDA, Ultravision Medical Equipment Trading L.L.C., Neusoft Corporation, Elekta AB, alltech Medical Systems America, FONAR Corp, Bruker, Aspect Imaging Ltd., ASG Superconductors spa, MinFound Medical Systems Co., Ltd and Synaptive Medical are the major players operating in the North America Brain MRI Scan Market.
TThe risks incurred while using the MRI devices and lack of cure for this neurological condition are poised to restrict the North America Brain MRI Scan Market growth.